External beam radiation therapy improves survival in low-volume metastatic prostate cancer patients: a North American population-based study-Reference-Cited by-同舟云学术

External beam radiation therapy improves survival in low-volume metastatic prostate cancer patients: a North American population-based study

Published:2020-09-01 Issue:1 Volume:24 Page:253-260
ISSN:1365-7852
Container-title:Prostate Cancer and Prostatic Diseases
language:en
Short-container-title:Prostate Cancer Prostatic Dis

Author:

Stolzenbach Lara Franziska^ORCID,Deuker Marina,Collà-Ruvolo Claudia^ORCID,Nocera Luigi,Mansour Mila,Tian Zhe,Tilki Derya^ORCID,Steuber Thomas,Briganti Alberto,Saad Fred,Chun Felix K. H.,Graefen Markus,Karakiewicz Pierre I.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Urology,Oncology

Link

https://www.nature.com/articles/s41391-020-00276-2.pdf

Reference21 articles.

1. Mohler JL, Higano CS, Pugh TJ. NCCN Guidelines index table of contents discussion. Prostate Cancer. Version 4.2019, 2019;166:MS-22.

2. Sweeney CJ, Chen Y-H, Carducci M, Liu G, Jarrard DF, Eisenberger M, et al. Chemohormonal therapy in metastatic hormone-sensitive prostate cancer. N Engl J Med. 2015;373:737–46. https://doi.org/10.1056/NEJMoa1503747.

3. Parker CC, James ND, Brawley CD, Clarke NW, Hoyle AP, Ali A, et al. Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial. Lancet. 2018;392:2353–66. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)32486-3/abstract.

4. Boevé LMS, Hulshof MCCM, Vis AN, Zwinderman AH, Twisk JWR, Witjes WPJ, et al. Effect on survival of androgen deprivation therapy alone compared to androgen deprivation therapy combined with concurrent radiation therapy to the prostate in patients with primary bone metastatic prostate cancer in a prospective randomised clinical trial: data from the HORRAD trial. Eur Urol. 2019;75:410–8. https://www.europeanurology.com/article/S0302-2838(18)30658-4/abstract.

5. Knipper S, Beyer B, Mandel P, Tennstedt P, Tilki D, Steuber T, et al. Outcome of patients with newly diagnosed prostate cancer with low metastatic burden treated with radical prostatectomy: a comparison to STAMPEDE arm H. World J Urol. 2019;38:1459–64.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment patterns and oncological outcomes of older adults with metastatic prostate cancer in real‐world setting;Journal of the American Geriatrics Society;2024-06-26

2. A Nomogram-Based Model to Predict Respiratory Dysfunction at 6 Months in Non-Critical COVID-19 Survivors;Frontiers in Medicine;2022-02-23

3. Survival rates with external beam radiation therapy in newly diagnosed elderly metastatic prostate cancer patients;The Prostate;2021-10-11

4. Validation of Cancer Diagnosis Based on the National Health Insurance Service Database versus the National Cancer Registry Database in Korea;Cancer Research and Treatment;2021-08-02

5. Survival in Patients With Metastatic Prostate Cancer Undergoing Radiotherapy: The Importance of Prostate-Specific Antigen-Based Stratification;Frontiers in Oncology;2021-06-10